Differences in the ischemic-hemorrhagic balance between diabetic and non-diabetic patients treated with dual antiplatelet theraphy with ticagrelor and prasugrel

25 August 2018 (00:00 - 00:00)
Organised by:
Congress Presentation Part of: Bleeding complications in ACS Postinfarction Period ESC Premium Access ESC Congress 2018

ESC 365 is supported by

ESC 365 is supported by